• Home
• About Us
• Aesthetic Medicine Training
  • Botox Training
  • Hands-On Botox and Dermal Filler Training
  • MedSpa / Aesthetic Practice Business Traininig
• Resources
  • Magazines and Periodicals and Other Links
  • More Resources
  • Associations
  • Events
  • International Aesthetic Medicine Resources
  • Archives
• Consumer Information

Subscribe

Joining the IAPAM Gives Physicians Access to Botox Training and Best Practices

Membership in IAPAM provides botox training, hCG training and business resources to physicians who are adding aesthetic medicine procedures to their practice.  Support from the IAPAM includes industry leading botox training, hCG for weight loss training, and hands-on education in dermal fillers, medical microdermabrasion, medical grade chemical peels and lasers & light devices. Today, the IAPAM announces that when you join, new members will get a copy of the IAPAM’s latest Best Practices e_book, The IAPAM’s Best Practices for the Injection of  Botulinum Toxin Type A (Botox).

The International Association for Physicians in Aesthetic Medicine (IAPAM) is the most accessible, global association for physicians looking for botox training or to add hCG for weight loss or other aesthetic medicine modalities to a practice.  Through membership in the IAPAM, coupled with attending any of the IAPAM’s comprehensive Aesthetic Medicine Symposiums, physicians ensure they have all the tools and expertise they will need to launch a safe and profitable medical spa. 

From the resources to significant discounts on training, membership in the IAPAM pays for itself.  For physicians who require equipment, financing, or marketing materials, membership with the IAPAM offers savings that will quickly pay for the annual $295 membership fee. In addition, IAPAM members have access to over 45 AMA CAT1 Aesthetic Medicine and Obesity related CME’s, via the IAPAM’s online Members web portal.  Finally, the monthly clinical and marketing tips members receive are proven to help a healthcare provider lower their expenses and increase revenues.  Read more

               

Medicine 3.0: 25 Excellent Social Media Sites for Your Health

Recently, Health 2.0 reported that 34 percent of Americans turn to social media for health research. Their information, based upon an iCrossing report, shows that consumers choose Wikipedia, online forums and message boards as their most favored resources for information. Additionally, while these users are looking for answers, they also seek support and interaction.

Interaction is what makes social media a bit different than Web 2.0. While Web 2.0 provides the tools for interaction between a user and a Web site, it may not provide the interaction required for a true “social” experience between the user and other users or site participants. For instance, teens and some adults who have disabilities and diseases such as cancer already use social-networking sites such as Facebook and MySpace.com to connect with peers.

Social media is not “top down” information with little to no interaction. While government groups struggle to impart information such as the latest news about tainted peanut butter products through blogs, Twitter and other Web 2.0 tools, others know that this isn’t enough. When you impart information, you also must respond. It is the era of the consumer, and the consumer is in control.

While some government groups still struggle with social interaction, many grassroots groups and visionaries ‘get it.’ The following 25 sites — among many dozens of other consumer-oriented social media sites — provide venues for patients, advocates, medical personnel, and others to interact on a level playing field. These tools allow news to flow freely, collaboration to become second-nature and support to become as pandemic as the diseases that threaten today’s populations.

The following sites are listed alphabetically under each category. This methodology shows that we do not favor one site over another.  Instead of top-down news and information, these sites provide information based upon user-generated input. You can read the latest news about any medical condition or offer and receive support and advice at these sites. Read more

               

Botox to be tested for Treating Cold Sores

A treatment used to get rid of wrinkles is being used for other purposes as well. Apparently, Botox is being used to treat the cold sores that occur in people suffering from the herpes simplex virus. The sores usually appear around the lips of people suffering from the condition.

Though, the infection does not appear in its nascent stages, yet once it’s activated, people end up suffering from cold sores, which appear on a regular basis.

The cosmetic procedure is being currently scrutinized to check, whether it can help people suffering from herpes. The research is being conducted by a group of researchers from the Chicago Centre for Facial Plastic Surgery in the United States. Read more

               

Botox Shots Approved for Migraine

The Food and Drug Administration approved Botox, the anti-wrinkle shot from Allergan, as a treatment to prevent chronic migraines, a little more than a month after the company agreed to pay $600 million to settle allegations that it had illegally marketed the drug for unapproved uses like headaches for years.

Allergan says sales of Botox for chronic migraine and other medical uses will eclipse sales of the drug as a wrinkle smoother.   The agency’s decision endorses doctors’ use of Botox to treat patients who suffer from a severe form of migraine involving headaches on at least 15 days a month. Britain’s drug agency approved Botox for the same use this summer.

Botox is already approved by the F.D.A. to treat uncontrolled blinking; crossed eyes; certain neck muscle spasms; excessive underarm sweating; and stiffness associated with muscle spasticity in the elbows and hands. It also is approved for cosmetic purposes — to smooth lines between the eyebrows.

Botox had worldwide sales last year of about $1.3 billion, divided equally between medical and cosmetic uses. Read more

               

IAPAM Supports Physicians as they Capitalize on $121 Billion Weight Loss Market

The IAPAM’s hCG Training for Physicians provides doctors with all the education and resources they need to capture a portion of the $3.6 billion dollar market for weight management pharmaceuticals.  Over 350 physicians have attended the IAPAM’s hCG Training in 2010, and are now poised to capture the “2011 New Year Resolution” market for loosing weight.  Don’t miss this opportunity to add hCG Medical Weight Loss to your practice.

An October 2010 study by BCC Research announced that “the 2009 market for weight loss products and services was worth nearly $121 billion.  The BCC study “anticipates this market will grow at a rate of 2.2%, resulting in a projected market size of more than $134 billion in 2014.  Pharmaceutical interventions, including hCG, are the second-largest product segment, after foods and beverages.  Retail sales in 2009 topped $3.6 billion and are expected to grow to $3.9 billion in 5 years.  The IAPAM’s hCG Physician Weight Loss Training is the most accessible, one-day training available to help physicians add hCG to their practices and capitalize on this exploding market. Read more

               

Non-Surgical Aesthetic Enhancement with Bodily Energy Modulation: New Frontiers of Energy and Cosmetic Medicine

Part 1: Introduction

Acupuncture has been clinically defined in a variegated manner by energy medical practitioners.  H.H. Moffet 2009 review study powerfully demonstrated that Sham acupuncture is as efficacious as traditional acupuncture techniques.  This researcher utilized 229 articles showing that non-Chi channel points were as therapeutic as traditional methodologies.  He writes the following: “this study used a convenience sample of 229 articles from PubMed Search using the key word “acupuncture” and “limited to clinical trials” published in English in 2005 or 2006.  Studies were categorized as wrong points versus non-points and the use of normal insertion and the stimulation versus superficial insertion or minimal stimulation…  These findings cast doubt on the validity on the traditional acupuncture theories pertaining to point locations and indication.”1  Currently, many schools in the United States are teaching protocols that are possibly fraught with deceptive efficaciousness.  It is likely that this traditional paradigm may be misleading and erroneous.

There is no objective veracity for the construct of Chi channels or their associated points.  However, there is a plethora of empirical interest in the body’s metaphysiology.  Dr. Sam Parnia’s work on near-death experience or his Human Consciousness Project appears to substantiate that the human body possesses occult energy dynamics which are physiologically operational when sequestered from its corporal robustness.  Many Western medical researchers are working on projects to substantiate the validity of the etheric aspects of the human body.  Currently, this sphere of analysis is still quite hypothetical.  Read more

               

FDA Says No — At Least for Now — to Arena’s Weight-Loss Pill - lorcaserin

Arena Pharmaceuticals said early Saturday morning that the FDA won’t approve the company’s weight-loss drug lorcaserin without further data to support the drug’s efficacy and safety.

That wasn’t a terribly big surprise, given that an outside FDA advisory panel last month voted not to recommend approval. The FDA has questions about the possibility of a higher incidence of tumors in rats dosed with the drug, Arena said in a press release. And the agency wants to see data on how well the drug works in diabetic patients. “We will work with the FDA to address the issues with our [application] as soon as possible,” Arena President and CEO Jack Lief said in a statement.

But as the WSJ reports, satisfying the FDA may take more clinical trials, and those take time and money. The WSJ also reports that the company’s development partner for lorcaserin, Japan’s Eisai, said it “remains committed to working with Arena” but didn’t elaborate on what its options for the partnership are from here on out.

Meantime, the FDA is due to issue a decision on another weight-loss drug — Qnexa, made by Vivus — later this week. In July, an FDA advisory panel voted not to recommend approval of the drug, citing a need for longer-term data to assuage safety concerns. Yet another experimental diet drug, Orexigen’s Contrave, is scheduled for consideration by the panel on Dec. 7, with a decision due by the end of January. Read more

               

Hasta La Vista, Meridia: Another Diet Drug Bites the Dust

Abbott’s removal of Meridia from the U.S. market — at the FDA’s request — means there’s just one weight-loss therapy approved for long-term use in a country where 68% of the population is overweight or obese.

(As the WSJ reports, Abbott also pulled the drug in Canada and Australia today. Regulators removed Meridia from the European market back in January.)

The FDA said Meridia carries unacceptably high heart risks, considering what it calls the “very modest weight loss” seen in those taking the drug, which was approved in 1997. A study published last month in the New England Journal of Medicine found a higher risk of heart attack and stroke among patients with existing cardiovascular conditions. Read more

               

IAPAM’s hCG Program Includes Enhanced Weight Loss Maintenance Strategies

The IAPAM’s hCG Physician Weight Loss Program offers physicians all the resources and training they need to add hCG for Weight Loss to their practices.  Now the IAPAM’s program includes enhanced education on long term weight loss maintenance strategies.

The IAPAM is committed to educating physicians on the best practices for using hCG as part of a successful Medical Weight Loss Program.  Now the exclusive IAPAM hCG Protocol has augmented its program to include proven strategies for the long term maintenance of weight loss after a successful hCG Protocol. “The goal is for patients to do the hCG program to get the weight off and keep it off forever, so these strategies will help physicians educate patients on what really works for long term weight loss,” says IAPAM executive-director, Jeff Russell.

A recent study published by the National Center for Biotechnology Information examined the “difference in selected weight loss strategies and attitudes among persons who reported successful weight loss attempts vs. persons who were not successful.  Behaviors examined included: modification of diet, leisure-time and sports activities, and self-monitoring.”  This study found that “self-monitoring strategies such as weighing oneself, planning meals, tracking fat and calories, exercising 30 or more minutes daily, and/or adding physical activity to daily routine may be important in successful weight loss maintenance. Leisure-time activities such as lifting weights or cooking/baking for fun are common strategies reported by those who were successful weight losers.” Read more

               

IAPAM’s hCG Training Prepares Physicians for Weight Loss Resolutions

The IAPAM’s December 3rd session of its comprehensive hCG Physician Weight Loss Training program is the final hCG Training Session of 2010.  For physicians who want to add hCG for Weight Loss to their practices in preparation for the flood of patients on January 1, 2011, attendance at the December 3rd seminar is the last chance to be educated in the IAPAM’s Exclusive hCG Protocol, and receive all the resources and ongoing support needed to successfully and profitably add hCG for weight loss to a practice. 

Everyone wants to be healthier, more attractive and feel good about themselves, yet over 66 percent of adult Americans are considered overweight or obese by recent studies.  Therefore, it is not surprising that in a recent survey of almost 1500 people, “losing weight” was considered the most popular New Year’s Resolution for 2011. Therefore, to capitalize on this New Year weight loss market, December 3rd’s IAPAM hCG Physician Training program is the last training session available for physicians who want to add hCG for weight loss to their practices on January 1, 2011. 

The IAPAM’s hCG Physician Weight Loss Training offers physicians a full-day of intensive education on the clinical best practices of hCG for weight loss, lipotropic injections and Very Low Calorie Diet (VLCD) programs. Physicians and their staff will learn the exclusive IAPAM hCG for Weight Loss Protocol. The IAPAM’s program gives doctors “everything they need to start offering medical weight loss programs to their patients immediately upon returning to their practices,” emphasizes Jeff Russell, Executive Director of the IAPAM, and one of the IAPAM faculty instructors presenting at the IAPAM’s hCG training. Read more

               

Next Page »

IAPAM Aesthetic Medicine Resources

• Recent News

  • 2011 Statistics Confirm that Botox ® Training Helps Physicians Capture Industry’s 5% Growth
  • NICE unconvinced by Botox for migraine
  • 5 Percent Increase Leads to Second Consecutive Yearly Gain
  • Botox injected by unlicensed practitioners
  • Plastic Surgery and the Economy
  • Lasers lighting the way for enhanced treatment of melasma and tattoo removal
  • Fitness and Fatness Independently Linked With CVD Risk Factors
  • Physicians Testify that IAPAM’s Symposium with Botox ® Training is an “Exceptional Value”
  • Syneron Announces New Ground Breaking evolastin(TM) Procedure
  • Cynosure Receives FDA 510(k) Clearance for Cellulaze Cellulite Laser Workstation

Copyright © 2010 Aesthetic Medicine News · Sitemap · Privacy Policy & Terms of Use · Login